Research Highlights:
- Body roundness index — a measure to reflect abdominal body fat and height that some health care professionals believe better reflects the proportion of body fat and visceral fat than body mass index — may help to predict a person’s risk of developing cardiovascular disease, according to a new study.
- The analysis of almost 10,000 adults in China older than age 45, conducted from 2011 to 2020, determined that having a higher body roundness index level over a 6-year period was associated with an increased risk of cardiovascular disease by as much as 163%, even when medical, lifestyle and demographic factors were not considered.
- The study used data from the China Health and Retirement Longitudinal Study (CHARLS), an ongoing, nationally representative study of middle-aged and older adults living in 28 provinces across China.
DALLAS, Sept. 25, 2024 — Having a high body roundness index (BRI) over a 6-year period was associated with an increased risk of developing cardiovascular disease for adults older than age 45, according to new research published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association. Previous research has indicated that BRI, a measure to reflect abdominal fat and body shape, may be helpful to predict CVD risk.
Cardiovascular disease is the leading cause of death worldwide, with almost 20 million deaths annually, according to the American Heart Association’s Heart Disease and Stroke Statistics 2024 Update. Obesity is a significant modifiable risk factor for cardiovascular disease, and previous research has indicated that abdominal obesity may be a stronger risk factor for cardiovascular disease than general obesity.
BRI is an abdominal obesity-related index that combines waist circumference and height, reflecting the proportion of abdominal and visceral fat. In contrast, body mass index (BMI) only measures weight in relationship to height. Previous research has suggested that BRI is a valuable predictor of cardiovascular disease risk, and BRI may help determine the presence of insulin resistance and metabolic syndrome.
In this study, researchers evaluated the association of BRI with cardiovascular disease among participants in the China Health and Retirement Longitudinal Study (CHARLS), a nationally representative study of middle-aged and older adults in China.
“This is the first large study to evaluate BRI over time and how it may be associated with the incidence of cardiovascular disease among middle-aged and older Chinese adults,” said senior study author Yun Qian, M.D., Ph.D., a researcher in the department of chronic non-communicable disease control at Nanjing Medical University’s Wuxi Center for Disease Control and Prevention in Nanjing, China.
Researchers analyzed BRI measurements from 2011 to 2016 and detailed the trajectory of BRI levels of the study participants. Rather than relying on a single measurement of the body roundness index, they analyzed trajectories of change in BRI over time, providing a comprehensive understanding of how the levels fluctuated in the study participants. Individuals who shared similar BRI trajectories were assigned to groups. Researchers then compared BRI trajectories for three groups: the low-stable BRI trajectory group, the moderate-stable BRI trajectory group and the high-stable BRI trajectory group.
The analysis determined that higher BRI trajectories were significantly associated with the risk of cardiovascular disease, and with increasing and persistently higher BRI measurements, a higher risk of developing cardiovascular disease, stroke or cardiac events was evident, independent of the participants’ age, sex or other variables. During the last four years of the follow-up period, from 2017 to 2020, there were 3,052 cardiovascular events recorded and 894 cardiovascular deaths.
The researchers found:
- Compared to participants in the low-stable BRI level group, the risk of cardiovascular disease in the moderate-stable BRI level group increased by 61%, and the risk in the high-stable BRI level group increased by 163%.
- When researchers accounted for demographic variables, medical history and cardiac medication history, significant differences in CVD were still observed in the moderate-stable BRI and high-stable BRI groups when compared to the low-stable BRI group.
- After further accounting for health measures, including blood pressure, blood glucose and cholesterol levels, the participants in the moderate-stable BRI group and the high-stable BRI group still had a higher risk of CVD diagnosis during the study period.
- The incidence of stroke and cardiac events was also significantly higher among participants in the moderate-stable and high-stable BRI level groups.
“Our findings indicate that 6 years of moderate-to-high stable BRI appeared to increase the risk of cardiovascular disease, suggesting that BRI measurements may potentially be used as a predictive factor for cardiovascular disease incidence,” Qian said. “This could be explained by the correlation between obesity and hypertension, high cholesterol and Type 2 diabetes, all of which are risk factors for cardiovascular disease. Obesity has also been shown to lead to inflammation and other mechanisms in the body that can affect the heart and cardiac functioning. More research is needed to confirm and fully understand how these results might be used to prevent cardiovascular disease.”
Study design, background and details:
- The study analyzed the health data for more than 9,935 adults living in China, ages 45 years and older, with an average age of 58 years at the beginning of the study. 53% of participants self-identified as men and 47% as women. All participants in the study analysis group had not reported a physician diagnosis of cardiovascular disease from 2011 to 2015.
- Participants were located in 150 counties across 28 provinces, and the sample used the lowest level of government organization - administrative villages in rural areas and neighborhoods in urban areas - as primary sampling units.
- Participants’ waist circumference and height were measured by medical staff from the Chinese Center for Disease Control and Prevention at their households when they enrolled in the study. Follow-up measurements were taken every two years by medical staff. The body roundness index of each participant was calculated using a standard formula factoring in waist circumference and height.
- Blood samples from participants were also collected at enrollment, which was in 2011-2012, and again in 2013-2014. This study used blood samples from 2011-2012.
- Blood pressure measurements were taken by medical staff with an electronic blood pressure monitor after five minutes of rest in the sitting position. The analysis used the average of three measurements taken at each visit; there were two visits in 2011-2012 and in 2013-2014.
- Staff also recorded participants’ health history and demographic information, including the presence of chronic disease and lifestyle risk factors.
- The participants were asked to self-report throughout the study follow-up period if they had been diagnosed by a health professional with a heart attack, stroke, angina, coronary heart disease, heart failure or other heart conditions.
The study had some limitations, including that it was specific to adults living in China, meaning the results may not be generalizable to people living in other countries. The follow-up period of the study was six years, which may be too brief to assess changes in BRI measurements. Additionally, the diagnosis of cardiovascular disease was based upon information from participants rather than medical records, which may have included information bias or errors.
Co-authors, disclosures and funding sources are listed in the manuscript.
Studies published in the American Heart Association’s scientific journals are peer-reviewed. The statements and conclusions in each manuscript are solely those of the study authors and do not necessarily reflect the Association’s policy or position. The Association makes no representation or guarantee as to their accuracy or reliability. The Association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific Association programs and events. The Association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and biotech companies, device manufacturers and health insurance providers and the Association’s overall financial information are available here.
Additional Resources:
###